IP Library Granted Patent US 12,571,024
Granted Patent B2
US 12,571,024 · App. 17/820,856 · Granted Mar 10, 2026

Methods and compositions relating to covalently closed nucleic acids

Inventors: Rebecca Nugent (San Francisco, CA); Siyuan Chen (San Mateo, CA); Nathan Raynard (San Mateo, CA)
Assignee: Twist Bioscience Corporation
C12Q1/6806C12N15/1093C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,571,024
App. No.
17/820,856
Granted
Mar 10, 2026
Kind
B2
Abstract

Provided herein are methods, systems, and compositions for assembly of covalently closed double stranded nucleic acids. Provided herein are methods, systems, and compositions for assembly covalently closed double stranded nucleic acids for use in various downstream processes.

Claims (37)

1 . A method for assembly of a covalently closed double stranded nucleic acid, comprising:

(a) providing a double stranded nucleic acid;

(b) amplifying the double stranded nucleic acid using a primer comprising one or more uracils to generate a double stranded nucleic acid comprising one or more uracils at a 5′ end and a 3′ end;

(c) digesting the double stranded nucleic acid comprising one or more uracils at the 5′ end and the 3′ end using a glycosylase and a glycosylase-lyase to generate a double stranded nucleic acid comprising a loop structure at the 5′ end and the 3′ end; and

(d) ligating gaps in the double stranded nucleic acid comprising the loop structure at the 5′ end and the 3′ end using a ligase to generate the covalently closed double stranded nucleic acid,

wherein the primer comprises a nucleic acid sequence according to SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8.

2 . The method of claim 1 , wherein the double stranded nucleic acid is deoxyribonucleic acid.

3 . The method of claim 1 , wherein the double stranded nucleic acid is linear.

4 . The method of claim 1 , wherein the glycosylase comprises base excision activity.

5 . The method of claim 4 , wherein the base excision activity of the glycosylase generates an abasic site.

6 . The method of claim 1 , wherein the glycosylase excises the one or more uracils.

7 . The method of claim 1 , wherein the glycosylase is AlkA, 3-methyladenine DNA glycosylase II, Mag1, MPG, SMUG1, MBD4, NTHL1, uracil DNA glycosylases, helix-hairpin-helix (HhH) glycosylases, or 3-methyl-purine glycosylase (MPG).

8 . The method of claim 5 , wherein the glycosylase-lyase breaks the phosphodiester backbone at a 3′ and 5′ sides of the abasic site.

9 . The method of claim 1 , wherein the glycosylase-lyase is Endonuclease VIII.

10 . The method of claim 1 , wherein the loop structure comprises at most about 40 bases.

11 . The method of claim 1 , wherein the loop structure comprises a sequence according to any one of SEQ ID NOs: 9-20.

12 . The method of claim 1 , wherein step (c) comprises excision of the one or more uracils.

13 . The method of claim 1 , wherein the method does not require heating between step (c) and step (d).

14 . A covalently closed double stranded nucleic acid generated by the method of claim 1 .

15 . A method for assembly of a covalently closed double stranded nucleic acid, comprising:

(a) providing a double stranded nucleic acid;

(b) amplifying the double stranded nucleic acid using a primer comprising one or more uracils to generate a double stranded nucleic acid comprising one or more uracils at a 5′ end and a 3′ end;

(c) digesting the double stranded nucleic acid comprising one or more uracils at the 5′ end and the 3′ end using a glycosylase and a glycosylase-lyase to generate a double stranded nucleic acid comprising a loop structure at the 5′ end and the 3′ end; and

(d) ligating gaps in the double stranded nucleic acid comprising the loop structure at the 5′ end and the 3′ end using a ligase to generate the covalently closed double stranded nucleic acid,

wherein the loop structure comprises a nucleic acid sequence according to SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, or SEQ ID NO: 20.

16 . The method of claim 15 , wherein the double stranded nucleic acid is deoxyribonucleic acid.

17 . The method of claim 15 , wherein the double stranded nucleic acid is linear.

18 . The method of claim 15 , wherein the glycosylase comprises base excision activity.

19 . The method of claim 18 , wherein the base excision activity of the glycosylase generates an abasic site.

20 . The method of claim 15 , wherein the glycosylase excises the one or more uracils.

21 . The method of claim 15 , wherein the glycosylase is AlkA, 3-methyladenine DNA glycosylase II, Mag1, MPG, SMUG1, MBD4, NTHL1, uracil DNA glycosylases, helix-hairpin-helix (HhH) glycosylases, or 3-methyl-purine glycosylase (MPG).

22 . The method of claim 19 , wherein the glycosylase-lyase breaks the phosphodiester backbone at a 3′ and 5′ sides of the abasic site.

23 . The method of claim 15 , wherein the glycosylase-lyase is Endonuclease VIII.

24 . The method of claim 15 , wherein the loop structure comprises at most about 40 bases.

25 . The method of claim 15 , wherein step (c) comprises excision of the one or more uracils.

26 . The method of claim 15 , wherein the method does not require heating between step (c) and step (d).

27 . A covalently closed double stranded nucleic acid generated by the method of claim 15 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2026
From: NUGENT, REBECCA; CHEN, SIYUAN; RAYNARD, NATHAN
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 073391/0617 →
Continuity (2)
Provisional Application 63235069 · Aug 19, 2021
Related Publication 20230115861A1 · Apr 13, 2023
References Cited (330)
US 5368823A · McGraw et al. · 1994 [cited by applicant]
US 5474796A · Brennan · 1995 [cited by applicant]
US 5534507A · Cama et al. · 1996 [cited by applicant]
US 5677195A · Winkler et al. · 1997 [cited by applicant]
US 5843767A · Beattie · 1998 [cited by applicant]
US 6013440A · Lipshutz et al. · 2000 [cited by applicant]
US 6028189A · Blanchard · 2000 [cited by applicant]
US 6419883B1 · Blanchard · 2002 [cited by applicant]
US 6472147B1 · Janda et al. · 2002 [cited by applicant]
US 6492107B1 · Kauffman et al. · 2002 [cited by applicant]
US 6893816B1 · Beattie · 2005 [cited by applicant]
US 7163660B2 · Lehmann · 2007 [cited by applicant]
US 7202264B2 · Ravikumar et al. · 2007 [cited by applicant]
US 8198071B2 · Goshoo et al. · 2012 [cited by applicant]
US 9403141B2 · Banyai et al. · 2016 [cited by applicant]
US 9409139B2 · Banyai et al. · 2016 [cited by applicant]
US 9555388B2 · Banyai et al. · 2017 [cited by applicant]
US 9677067B2 · Toro et al. · 2017 [cited by applicant]
US 9745619B2 · Rabbani et al. · 2017 [cited by applicant]
US 9765387B2 · Rabbani et al. · 2017 [cited by applicant]
US 9833761B2 · Banyai et al. · 2017 [cited by applicant]
US 9839894B2 · Banyai et al. · 2017 [cited by applicant]
US 9889423B2 · Banyai et al. · 2018 [cited by applicant]
US 9895673B2 · Peck et al. · 2018 [cited by applicant]
US 9981239B2 · Banyai et al. · 2018 [cited by applicant]
US 10053688B2 · Cox · 2018 [cited by applicant]
US 10272410B2 · Banyai et al. · 2019 [cited by applicant]
US 10384188B2 · Banyai et al. · 2019 [cited by applicant]
US 10384189B2 · Peck · 2019 [cited by applicant]
US 10417457B2 · Peck · 2019 [cited by applicant]
US 10583415B2 · Banyai et al. · 2020 [cited by applicant]
US 10618024B2 · Banyai et al. · 2020 [cited by applicant]
US 10632445B2 · Banyai et al. · 2020 [cited by applicant]
US 10639609B2 · Banyai et al. · 2020 [cited by applicant]
US 10669304B2 · Indermuhle et al. · 2020 [cited by applicant]
US 10744477B2 · Banyai et al. · 2020 [cited by applicant]
US 10754994B2 · Peck · 2020 [cited by applicant]
US 10773232B2 · Banyai et al. · 2020 [cited by applicant]
US 10844373B2 · Cox et al. · 2020 [cited by applicant]
US 10894242B2 · Marsh et al. · 2021 [cited by applicant]
US 10894959B2 · Cox et al. · 2021 [cited by applicant]
US 10907274B2 · Cox · 2021 [cited by applicant]
US 10936953B2 · Bramlett et al. · 2021 [cited by applicant]
US 10969965B2 · Malina et al. · 2021 [cited by applicant]
US 10975372B2 · Cox et al. · 2021 [cited by applicant]
US 10987648B2 · Peck et al. · 2021 [cited by applicant]
US 11185837B2 · Banyai et al. · 2021 [cited by applicant]
US 11214798B2 · Brown · 2022 [cited by applicant]
US 11263354B2 · Peck · 2022 [cited by applicant]
US 11332738B2 · Nugent et al. · 2022 [cited by applicant]
US 11332740B2 · Nugent et al. · 2022 [cited by applicant]
US 11377676B2 · Wu et al. · 2022 [cited by applicant]
US 11407837B2 · Glanville · 2022 [cited by applicant]
US 11452980B2 · Banyai et al. · 2022 [cited by applicant]
US 11492665B2 · Zeitoun et al. · 2022 [cited by applicant]
US 11492727B2 · Tabibiazar et al. · 2022 [cited by applicant]
US 11492728B2 · Sato · 2022 [cited by applicant]
US 20010018512A1 · Blanchard · 2001 [cited by applicant]
US 20020025561A1 · Hodgson · 2002 [cited by applicant]
US 20020094533A1 · Hess et al. · 2002 [cited by applicant]
US 20020095073A1 · Jacobs et al. · 2002 [cited by applicant]
US 20020160536A1 · Regnier et al. · 2002 [cited by applicant]
US 20020164824A1 · Xiao et al. · 2002 [cited by applicant]
US 20030120035A1 · Gao et al. · 2003 [cited by applicant]
US 20030171325A1 · Gascoyne et al. · 2003 [cited by applicant]
US 20040087008A1 · Schembri · 2004 [cited by applicant]
US 20040259146A1 · Friend et al. · 2004 [cited by applicant]
US 20050137805A1 · Lewin et al. · 2005 [cited by applicant]
US 20050227235A1 · Carr et al. · 2005 [cited by applicant]
US 20060127920A1 · Church et al. · 2006 [cited by applicant]
US 20070196834A1 · Cerrina et al. · 2007 [cited by applicant]
US 20080085511A1 · Peck et al. · 2008 [cited by applicant]
US 20080085514A1 · Peck et al. · 2008 [cited by applicant]
US 20080227160A1 · Kool · 2008 [cited by applicant]
US 20080287320A1 · Baynes et al. · 2008 [cited by applicant]
US 20080300842A1 · Govindarajan et al. · 2008 [cited by applicant]
US 20090062129A1 · McKernan et al. · 2009 [cited by applicant]
US 20090239759A1 · Balch · 2009 [cited by applicant]
US 20090285825A1 · Kini et al. · 2009 [cited by applicant]
US 20100004143A1 · Shibahara · 2010 [cited by applicant]
US 20100099103A1 · Hsieh et al. · 2010 [cited by applicant]
US 20100111768A1 · Banerjee et al. · 2010 [cited by applicant]
US 20100216648A1 · Staehler et al. · 2010 [cited by applicant]
US 20100311960A1 · Dellinger · 2010 [cited by applicant]
US 20110172127A1 · Jacobson et al. · 2011 [cited by applicant]
US 20110217738A1 · Jacobson · 2011 [cited by applicant]
US 20120129704A1 · Gunderson et al. · 2012 [cited by applicant]
US 20120164691A1 · Eshoo et al. · 2012 [cited by applicant]
US 20120231968A1 · Bruhn et al. · 2012 [cited by applicant]
US 20120264653A1 · Carr et al. · 2012 [cited by applicant]
US 20130017642A1 · Milgrew et al. · 2013 [cited by applicant]
US 20130017977A1 · Oleinikov · 2013 [cited by applicant]
US 20130065017A1 · Sieber · 2013 [cited by applicant]
US 20130109595A1 · Routenberg · 2013 [cited by applicant]
US 20130109596A1 · Peterson et al. · 2013 [cited by applicant]
US 20130130321A1 · Staehler et al. · 2013 [cited by applicant]
US 20130165328A1 · Previte et al. · 2013 [cited by applicant]
US 20140106394A1 · Ko et al. · 2014 [cited by applicant]
US 20140178992A1 · Nakashima et al. · 2014 [cited by applicant]
US 20150038373A1 · Banyai et al. · 2015 [cited by applicant]
US 20150120265A1 · Amirav-Drory et al. · 2015 [cited by applicant]
US 20150196917A1 · Kay et al. · 2015 [cited by applicant]
US 20160089651A1 · Banyai · 2016 [cited by applicant]
US 20160090592A1 · Banyai et al. · 2016 [cited by applicant]
US 20160096160A1 · Banyai et al. · 2016 [cited by applicant]
US 20160251651A1 · Banyai et al. · 2016 [cited by applicant]
US 20160303535A1 · Banyai et al. · 2016 [cited by applicant]
US 20160333340A1 · Wu · 2016 [cited by applicant]
US 20160339409A1 · Banyai et al. · 2016 [cited by applicant]
US 20160340672A1 · Banyai et al. · 2016 [cited by applicant]
US 20160354752A1 · Banyai et al. · 2016 [cited by applicant]
US 20170081716A1 · Peck · 2017 [cited by applicant]
US 20170088833A1 · Joung · 2017 [cited by examiner]
US 20170095785A1 · Banyai et al. · 2017 [cited by applicant]
US 20170159044A1 · Toro et al. · 2017 [cited by applicant]
US 20170327819A1 · Banyai et al. · 2017 [cited by applicant]
US 20170357752A1 · Diggans · 2017 [cited by applicant]
US 20170362589A1 · Banyai et al. · 2017 [cited by applicant]
US 20180029001A1 · Banyai et al. · 2018 [cited by applicant]
US 20180104664A1 · Fernandez · 2018 [cited by applicant]
US 20180142289A1 · Zeitoun et al. · 2018 [cited by applicant]
US 20180253563A1 · Peck et al. · 2018 [cited by applicant]
US 20180264428A1 · Banyai et al. · 2018 [cited by applicant]
US 20180282721A1 · Cox et al. · 2018 [cited by applicant]
US 20180326388A1 · Banyai et al. · 2018 [cited by applicant]
US 20190194692A1 · Meijrink et al. · 2019 [cited by applicant]
US 20190314783A1 · Banyai et al. · 2019 [cited by applicant]
US 20190352635A1 · Toro et al. · 2019 [cited by applicant]
US 20190366293A1 · Banyai et al. · 2019 [cited by applicant]
US 20190366294A1 · Banyai et al. · 2019 [cited by applicant]
US 20200071713A1 · Sayre et al. · 2020 [cited by applicant]
US 20200102611A1 · Zeitoun et al. · 2020 [cited by applicant]
US 20200156037A1 · Banyai et al. · 2020 [cited by applicant]
US 20200181667A1 · Wu et al. · 2020 [cited by applicant]
US 20200222875A1 · Peck et al. · 2020 [cited by applicant]
US 20200283760A1 · Nugent et al. · 2020 [cited by applicant]
US 20200299322A1 · Indermuhle et al. · 2020 [cited by applicant]
US 20200299684A1 · Toro et al. · 2020 [cited by applicant]
US 20200330953A1 · Banyai et al. · 2020 [cited by applicant]
US 20210002710A1 · Gantt et al. · 2021 [cited by applicant]
US 20210040476A1 · Cox et al. · 2021 [cited by applicant]
US 20210071168A1 · Nugent et al. · 2021 [cited by applicant]
US 20210102192A1 · Tabibiazar et al. · 2021 [cited by applicant]
US 20210102195A1 · Sato et al. · 2021 [cited by applicant]
US 20210102198A1 · Cox et al. · 2021 [cited by applicant]
US 20210115594A1 · Cox et al. · 2021 [cited by applicant]
US 20210123098A1 · Previte et al. · 2021 [cited by applicant]
US 20210129108A1 · Marsh et al. · 2021 [cited by applicant]
US 20210142182A1 · Bramlett et al. · 2021 [cited by applicant]
US 20210164029A1 · Sekedat et al. · 2021 [cited by applicant]
US 20210170356A1 · Peck et al. · 2021 [cited by applicant]
US 20210179724A1 · Sato et al. · 2021 [cited by applicant]
US 20210180046A1 · Cox et al. · 2021 [cited by applicant]
US 20210207197A1 · Gantt et al. · 2021 [cited by applicant]
US 20210332078A1 · Wu · 2021 [cited by applicant]
US 20210348220A1 · Zeitoun et al. · 2021 [cited by applicant]
US 20210355194A1 · Sato et al. · 2021 [cited by applicant]
US 20210395344A1 · Sato et al. · 2021 [cited by applicant]
US 20220032256A1 · Lackey et al. · 2022 [cited by applicant]
US 20220064206A1 · Fernandez et al. · 2022 [cited by applicant]
US 20220064313A1 · Sato et al. · 2022 [cited by applicant]
US 20220064628A1 · Toro et al. · 2022 [cited by applicant]
US 20220106586A1 · Nugent et al. · 2022 [cited by applicant]
US 20220106590A1 · Arbiza et al. · 2022 [cited by applicant]
US 20220135690A1 · Sato et al. · 2022 [cited by applicant]
US 20220135965A1 · Gantt et al. · 2022 [cited by applicant]
US 20220138354A1 · Peck · 2022 [cited by applicant]
US 20220145289A1 · Lackey et al. · 2022 [cited by applicant]
US 20220206001A1 · Sato · 2022 [cited by applicant]
US 20220243195A1 · Nugent et al. · 2022 [cited by applicant]
US 20220246236A1 · Amirav-Drory · 2022 [cited by applicant]
US 20220259319A1 · Sato et al. · 2022 [cited by applicant]
US 20220259638A1 · Brown · 2022 [cited by applicant]
US 20220277808A1 · Arbiza et al. · 2022 [cited by applicant]
US 20220281989A1 · Glanville · 2022 [cited by applicant]
US 20220307010A1 · Sato et al. · 2022 [cited by applicant]
US 20220315971A1 · Wu et al. · 2022 [cited by applicant]
US 20220323924A1 · Lackey et al. · 2022 [cited by applicant]
US 20220325276A2 · Banyai et al. · 2022 [cited by applicant]
US 20220325278A1 · Nugent et al. · 2022 [cited by applicant]
US 20220348659A1 · Sato et al. · 2022 [cited by applicant]
CN 101277758A · 2008 [cited by applicant]
EP 3030682A2 · 2016 [cited by applicant]
JP H07505530A · 1995 [cited by applicant]
JP 2001518086A · 2001 [cited by applicant]
JP 2002538790A · 2002 [cited by applicant]
JP 2004268394A · 2004 [cited by applicant]
JP 2006503586A · 2006 [cited by applicant]
JP 2008214343A · 2008 [cited by applicant]
JP 2009294195A · 2009 [cited by applicant]
JP 2016527313A · 2016 [cited by applicant]
WO WO9320242A1 · 1993 [cited by applicant]
WO WO02072791A2 · 2002 [cited by applicant]
WO WO2005059096A2 · 2005 [cited by applicant]
WO WO2008054543A2 · 2008 [cited by applicant]
WO WO2008063135A1 · 2008 [cited by applicant]
WO WO2011109031A1 · 2011 [cited by applicant]
WO WO2012078312A2 · 2012 [cited by applicant]
WO WO2012154201A1 · 2012 [cited by applicant]
WO WO2013036685A1 · 2013 [cited by examiner]
WO WO2014021938A1 · 2014 [cited by applicant]
WO WO2015021080A2 · 2015 [cited by applicant]
WO WO2016132129A1 · 2016 [cited by examiner]
WO 2021152147A1 · 2021 [cited by applicant]
WO WO2022010934A2 · 2022 [cited by applicant]
WO WO2022076326A1 · 2022 [cited by applicant]
WO WO2022086866A1 · 2022 [cited by applicant]
WO WO2022087293A1 · 2022 [cited by applicant]
WO WO2022098662A2 · 2022 [cited by applicant]
WO WO2022159620A1 · 2022 [cited by applicant]
WO WO2022178137A1 · 2022 [cited by applicant]
WO WO2022204309A1 · 2022 [cited by applicant]
WO WO2022204316A2 · 2022 [cited by applicant]
WO WO2022217004A1 · 2022 [cited by applicant]
Agbavwe et al.: Efficiency, Error and Yield in Light-Directed Maskless Synthesis of DNA Microarrays. Journal of Nanobiotechnology. 9(57):1-17 (2011). [cited by applicant]
Altschul et al.: Basic Local Alignment Search Tool. J. Mol. Biol. 215: 403-410 (1990). [cited by applicant]
Altschul et al.: Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nuc. Acids Res. 25: 3389-3402 (1997). [cited by applicant]
Arkles et al.: The Role of Polarity in the Structure of Silanes Employed in Surface Modification. Silanes and Other Coupling Agents. 5:51-64 (2009). [cited by applicant]
ATDBio. Nucleic Acid Structure, Nucleic Acids Book, 9 pages, published on Jan. 22, 2005. from: http://www.atdbio.com/content/5/Nucleic-acid-structure. [cited by applicant]
ATDBio. Solid-Phase Oligonucleotide Synthesis, Nucleic Acids Book, 20 pages, Published on Jul. 31, 2011. from: http://www.atdbio.com/content/17/Solid-phase-oligonucleotide-synthesis. [cited by applicant]
BERG: Biochemistry. 5th ED. New York (2002) 148-149. [cited by applicant]
Blanchard et al.: High-Density Oligonucleotide Arrays. Biosensors & Bioelectronics, 11(6/7):687-690 (1996). [cited by applicant]
Buermans et al.: Next Generation sequencing technology: Advances and applications, Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1842:1931-1941 (2014). [cited by applicant]
Cheng et al.: High throughput parallel synthesis of oligonucleotides with 1536 channel synthesizer. Nucleic Acids Res. 30(18):e93 (2002). [cited by applicant]
Cleary et al.: Production of complex nucleic acid libraries using highly parallel in situ oligonucleotide synthesis. Nat Methods. 1(3):241-248 (2004). [cited by applicant]
Cohen et al.: Human population: The next half century. Science. 302:1172-1175 (2003). [cited by applicant]
Cruse et al.: Atlas of Immunology. Third Edition. Boca Raton:CRC Press (pp. 282-283) (2010). [cited by applicant]
Elsik et al.: The Genome sequence of taurine cattle: A window of ruminant biology and evolution. Science. 324:522-528 (2009). [cited by applicant]
Fodor et al.: Light-directed, spatially addressable parallel chemical synthesis. Science. 251(4995):767-773 (1991). [cited by applicant]
Gao et al.: A method for the generation of combinatorial antibody libraries using pIX phage display. PNAS 99(20):12612-12616 (2002). [cited by applicant]
GE Healthcare. AKTA oligopilot plus. Data File 18-114-66 ADC. 8 pages (2006). [cited by applicant]
GE Healthcare. Robust and cost-efficient oligonucleotide synthesis. Application Note 28-4058-08 AA. 4 pages (2005). [cited by applicant]
Gibson et al.: Creation of a Bacterial Cell Controlled by A Chemically Synthesized Genome. Science. 329(5989):52-56 (2010). [cited by applicant]
Hudson: Matrix Assisted Synthetic Transformations: A Mosaic of Diverse Contributions. Journal of Combinatorial Chemistry. 1(6):403-457 (1999). [cited by applicant]
Karlin et al.: Applications and statistics for multiple high-scoring segments in molecular sequences. PNAS USA 90:5873-5877 (1993). [cited by applicant]
Karlin et al.: Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. PNAS USA 87:2264-2268 (1990). [cited by applicant]
Kong et al.: Parallel gene synthesis in a microfluidic device. Nucleic Acids Res. 35(8):e61 (2007). [cited by applicant]
Kosuri and Church. Large-scale de novo DNA synthesis: technologies and applications. Nature Methods. 11:499-507 (2014) Available at: http://www.nature.com/nmeth/journal/v11/n5/full/nmeth.2918.html. [cited by applicant]
Kosuri et al.: A scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips. Nature Biotechnology. 2010; 28:1295-1299. [cited by applicant]
Kosuri et al.: A scalable gene synthesis platform using high-fidelity DNA microchips Nat.Biotechnol. 28(12):1295-1299 (2010). [cited by applicant]
Krayden, Inc.: A Guide to Silane Solutions. Silane coupling agents. 7 pages. Published on May 31, 2005 at: http://krayden.com/pdf/xia_silane_chemistry.pdf. [cited by applicant]
Lausted et al.: POSaM: a fast, flexible, open-source, inkjet oligonucleotide synthesizer and microarrayer. Genome Biology. 5:R58, 17 pages (2004) available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507883/. [cited by applicant]
Lebl et al.: Economical Parallel Oligonucleotide and Peptide Synthesizer—Pet Oligator. Int. J. Peptide Res. Ther. 13(1-2):367-376 (2007). [cited by applicant]
Leproust et al.: Synthesis of high-quality libraries of long (150mer) oligonucleotides by a novel depurination controlled process. Nucleic Acids Research. 38(8):2522-2540 (2010). [cited by applicant]
Lewontin and Harti. Population genetics in forensic DNA typing. Science, 254:1745-1750, 1991. [cited by applicant]
Ma et al.: DNA synthesis, assembly and application in synthetic biology. Current Opinion in Chemical Biology. 16:260-267 (2012). [cited by applicant]
Ma et al.: Versatile surface functionalization of cyclic olefin copolymer (COC) with sputtered SiO2 thin film for potential BioMEMS applications. Journal of Materials Chemistry. 11 pages (2009). [cited by applicant]
Mazor et al.: Isolation of Full-Length IgG Antibodies from Combinatorial Libraries Expressed in [cited by applicant]
McBride & Caruthers. An investigation of several deoxynucleoside phosphoramidites useful for synthesizing deoxyoligonucleotides. Tetrahedron Lett. 24:245-248 (1983). [cited by applicant]
Mitra et al.: In situ localized amplification and contact replication of many individual DNA molecules. Nucleic Acids Res. 27(24):e34 (1999). [cited by applicant]
Morin et al.: Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques. 45:81-94 (2008). [cited by applicant]
Opposition to European Patent No. 3030682 filed Mar. 3, 2021. [cited by applicant]
PCT/US2014/049834 International Preliminary Report on Patentability dated Feb. 18, 2016. [cited by applicant]
PCT/US2014/049834 International Search Report and Written Opinion mailed Mar. 19, 2015. [cited by applicant]
PCT/US2014/049834 Invitation to Pay Additional Fees mailed Jan. 5, 2015. [cited by applicant]
Pirrung. How to make a DNA chip. Angew. Chem. Int. Ed. 41:1276-1289 (2002). [cited by applicant]
Pray. Discovery of DNA Structure and Function: Watson and Crick. Nature Education.6 pages (2008) available at: http://www.nature.com/scitable/topicpage/discovery-of-dna-structure-and-function-watson-397. [cited by applicant]
Quan et al.: Parallel on-chip gene synthesis and application to optimization of protein expression. Nature Biotechnology. 29:449-452 (2011). [cited by applicant]
Rafalski and Morgante, Corn and humans: recombination and linkage disequilibrium in two genomes of similar size. Trends in Genetics. 20(2):103-111. (2004). [cited by applicant]
Rogozin et al.: Origin and evolution of spliceosomal introns. Biology Direct, 7:11 (2012). [cited by applicant]
Saaem et al.: In situ synthesis of DNA microarray on functionalized cyclic olefin copolymer substrate ACS Applied Materials & Interfaces. 2(2):491-497 (2010). [cited by applicant]
Sargolzaei et al.: Extent of linkage disequilibrium in Holstein cattle in North America. J.Dairy Science. 91:2106-2117 (2007). [cited by applicant]
Srivannavit et al.: Design and fabrication of microwell array chips for a solution-based, photogenerated acid-catalyzed parallel oligonucleotide DNA synthesis. Sensors and Actuators A. 116:150-160 (2004). [cited by applicant]
Steel. The Flow-Thru Chip A Three-dimensional biochip platform. In: Schena, Microarray Biochip Technology, Chapter 5, Natick, MA: Eaton Publishing, 2000, 33 pages. [cited by applicant]
Taylor et al.: Impact of surface chemistry and blocking strategies on DNA microarrays. Nucleic Acids Research, 31(16):e87 19 pages (2003). [cited by applicant]
Tian et al.: Accurate multiplex gene synthesis from programmable DNA microchips. Nature. 432(7020):1050-1054 (2004). [cited by applicant]
U.S. Appl. No. 16/737,401 Final Office Action dated Jun. 13, 2022. [cited by applicant]
U.S. Appl. No. 14/452,429 Notice of Allowance dated Jun. 7, 2016. [cited by applicant]
U.S. Appl. No. 14/452,429 Office Action mailed Apr. 9, 2015. [cited by applicant]
U.S. Appl. No. 14/452,429 Office Action mailed Oct. 21, 2015. [cited by applicant]
U.S. Appl. No. 14/452,429 Restriction Requirement mailed Dec. 12, 2014. [cited by applicant]
U.S. Appl. No. 14/885,962 Notice of Allowance dated Nov. 8, 2017 and Sep. 29, 2017. [cited by applicant]
U.S. Appl. No. 14/885,962 Office Action dated Dec. 16, 2016. [cited by applicant]
U.S. Appl. No. 14/885,962 Office Action dated Sep. 8, 2016. [cited by applicant]
U.S. Appl. No. 14/885,962 Restriction Requirement dated Mar. 1, 2016. [cited by applicant]
U.S. Appl. No. 14/885,963 Notice of Allowance dated May 24, 2016. [cited by applicant]
U.S. Appl. No. 14/885,963 Office Action dated Feb. 5, 2016. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Aug. 28, 2018. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Aug. 30, 2017. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Feb. 10, 2017. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Feb. 18, 2016. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Jan. 4, 2018. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Jul. 7, 2016. [cited by applicant]
U.S. Appl. No. 15/187,714 Final Office Action dated Sep. 17, 2019. [cited by applicant]
U.S. Appl. No. 15/187,714 Office Action dated Apr. 4, 2019. [cited by applicant]
U.S. Appl. No. 15/187,714 Restriction Requirement dated Sep. 17, 2018. [cited by applicant]
U.S. Appl. No. 15/187,721 Notice of Allowance dated Dec. 7, 2016. [cited by applicant]
U.S. Appl. No. 15/187,721 Office Action dated Oct. 14, 2016. [cited by applicant]
U.S. Appl. No. 15/233,835 Notice of Allowance dated Oct. 4, 2017. [cited by applicant]
U.S. Appl. No. 15/233,835 Office Action dated Feb. 8, 2017. [cited by applicant]
U.S. Appl. No. 15/233,835 Office Action dated Jul. 26, 2017. [cited by applicant]
U.S. Appl. No. 15/233,835 Restriction Requirement dated Nov. 4, 2016. [cited by applicant]
U.S. Appl. No. 15/245,054 Notice of Allowance dated Dec. 14, 2017. [cited by applicant]
U.S. Appl. No. 15/245,054 Office Action dated Mar. 21, 2017. [cited by applicant]
U.S. Appl. No. 15/245,054 Office Action dated Oct. 19, 2016. [cited by applicant]
U.S. Appl. No. 15/377,547 Final Office Action dated Feb. 8, 2019. [cited by applicant]
U.S. Appl. No. 15/377,547 Office Action dated Jul. 27, 2018. [cited by applicant]
U.S. Appl. No. 15/377,547 Office Action dated Mar. 24, 2017. [cited by applicant]
U.S. Appl. No. 15/377,547 Office Action dated Nov. 30, 2017. [cited by applicant]
U.S. Appl. No. 15/602,991 Final Office Action dated Dec. 13, 2018. [cited by applicant]
U.S. Appl. No. 15/602,991 Notice of Allowance dated Oct. 25, 2017. [cited by applicant]
U.S. Appl. No. 15/602,991 Office Action dated May 31, 2018. [cited by applicant]
U.S. Appl. No. 15/602,991 Office Action dated May 31, 2019. [cited by applicant]
U.S. Appl. No. 15/602,991 Office Action dated Sep. 21, 2017. [cited by applicant]
U.S. Appl. No. 15/603,013 Final Office Action dated Nov. 6, 2019. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Jan. 30, 2018. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Jul. 10, 2018. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Jun. 26, 2019. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Oct. 20, 2017. [cited by applicant]
U.S. Appl. No. 15/729,564 Final Office Action dated Dec. 13, 2018. [cited by applicant]
U.S. Appl. No. 15/729,564 Office Action dated Jan. 8, 2018. [cited by applicant]
U.S. Appl. No. 15/729,564 Office Action dated Jun. 6, 2018. [cited by applicant]
U.S. Appl. No. 15/729,564 Office Action dated May 30, 2019. [cited by applicant]
U.S. Appl. No. 15/991,992 Office Action dated May 21, 2020. [cited by applicant]
U.S. Appl. No. 15/991,992 Restriction Requirement dated Mar. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/039,256 Final Office Action dated Mar. 30, 2021. [cited by applicant]
U.S. Appl. No. 16/039,256 Office Action dated Aug. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/039,256 Office Action dated May 10, 2022. [cited by applicant]
U.S. Appl. No. 16/039,256 Restriction Requirement dated May 18, 2020. [cited by applicant]
U.S. Appl. No. 16/409,608 Office Action dated Sep. 9, 2019. [cited by applicant]
U.S. Appl. No. 16/535,777 Final Office Action dated Oct. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/535,777 Office Action dated Feb. 8, 2021. [cited by applicant]
U.S. Appl. No. 16/535,777 Office Action dated Jan. 23, 2020. [cited by applicant]
U.S. Appl. No. 16/535,779 First Action Interview dated Feb. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/737,401 Office Action dated Jan. 5, 2022. [cited by applicant]
U.S. Appl. No. 16/737,401 Restriction Requirement dated Nov. 15, 2021. [cited by applicant]
Van Tassell et al.: SNP discovery and allele frequency estimation by deep sequencing of reduced representation libraries. Nature Methods. 5:247-252 (2008). [cited by applicant]
Wootton et al. Statistics of local complexity in amino acid sequences and sequence databases. Computers & Chemistry 17(2):149-163 (Jun. 1993). [cited by applicant]
Xu et al.: Design of 240,000 orthogonal 25mer DNA barcode probes. PNAS. 106(7):2289-2294 (2009). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2022/040813, mailed on Jun. 7, 2023, 13 pages. [cited by applicant]